Related Experiment Video

Updated: Jun 5, 2026

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on: September 18, 2013

The Family Physician's Role in Managing Chronic Leukemia

P R Galbraith

    Canadian Family Physician Medecin De Famille Canadien
    |January 22, 2011
    PubMed

    Insights

    This article updates the clinical approach for chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL). It covers advances in pathobiology and new treatment policies for these common chronic leukemias.

    Area of Science:

    • Hematology
    • Oncology
    • Internal Medicine

    Background:

    • Chronic leukemias, including chronic myelogenous leukemia (CML) and chronic lymphocytic leukemia (CLL), are common hematologic malignancies.
    • Family physicians often manage the day-to-day care of patients with these conditions.

    Purpose of the Study:

    • To provide an update on the clinical management of CML and CLL.
    • To discuss how advances in pathobiology influence current treatment strategies.
    • To inform family physicians about the latest concepts in chronic leukemia management.

    Main Methods:

    • Review of recent scientific literature on CML and CLL pathobiology.
    • Analysis of emerging treatment policies and clinical guidelines.
    • Focus on practical implications for primary care physicians.

    Main Results:

    • Pathobiological advances have significantly refined understanding of CML and CLL.
    • New therapeutic concepts are altering standard treatment protocols.
    • Updated clinical approaches are essential for optimal patient outcomes.

    Conclusions:

    • Continuous learning on CML and CLL is crucial for effective patient management.
    • Advances in understanding leukemia pathobiology directly impact treatment decisions.
    • Family physicians play a vital role in the long-term care of chronic leukemia patients.

    More Related Videos

    Modeling Chemotherapy Resistant Leukemia In Vitro08:41

    Modeling Chemotherapy Resistant Leukemia In Vitro

    Published on: February 9, 2016

    Related Concept Videos

    Chronic Kidney Disease IV: Nursing Management01:18

    Chronic Kidney Disease IV: Nursing Management

    Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of fluid...
    Nursing Ethical Principles II01:27

    Nursing Ethical Principles II

    Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
    Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
    Initially, Mr. John's cancer...
    Chronic Kidney Disease III: Interprofessional Care01:28

    Chronic Kidney Disease III: Interprofessional Care

    Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
    Combination Therapies and Personalized Medicine02:50

    Combination Therapies and Personalized Medicine

    Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
    The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
    Chronic Pancreatitis II: Collaborative Care01:29

    Chronic Pancreatitis II: Collaborative Care

    The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
    Assessment:
    Esophageal Varices-II: Clinical Features and Management01:28

    Esophageal Varices-II: Clinical Features and Management

    Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
    In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...